| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |